Crown Bioscience collaborates with Jiangsu Qyun Bio-Pharmaceutical to develop antibody
Crown Bioscience announced collaboration with Jiangsu Qyun Bio-Pharmaceutical to develop antibody. The goal of the collaboration is to develop a less toxic CTLA-4 antibody and better…
Read More...
Read More...
